RecruitingPhase 4NCT06866691
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
Studying Moderate and severe traumatic brain injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wake Forest University Health Sciences
- Principal Investigator
- Rita Brintzenhoff, MDAtrium Health Carolina Medical Center
- Intervention
- levetiracetam(drug)
- Enrollment
- 600 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06866691 on ClinicalTrials.govOther trials for Moderate and severe traumatic brain injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06241482Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical CareShanghai 6th People's Hospital
- RECRUITINGPHASE1, PHASE2NCT06282965Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain InjuryUniversity of Arizona
- RECRUITINGPHASE1NCT05716048Combinatory Rehabilitation Used for Substantially Helping Individuals With Traumatic Brain InjuryKessler Foundation
- ACTIVE NOT RECRUITINGNANCT05636020Intervention to Change Affect Recognition and EmpathyIndiana University
See all trials for Moderate and severe traumatic brain injury →